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ABSTRACT
The 5=-terminal sequence of the hepatitis C virus (HCV) positive-strand RNA genome is essential for viral replication. Critical
host factors, including a miR-122/Ago2 complex and poly(rC)-binding protein 2 (PCBP2), associate with this RNA segment. We
used a biotinylated RNA pulldown approach to isolate host factors binding to the HCV 5= terminal 47 nucleotides and, in addi-
tion to Ago2 and PCBP2, identified several novel proteins, including IGF2BP1, hnRNP L, DHX9, ADAR1, and NF90 (ILF3).
PCBP2, IGF2BP1, and hnRNP L bound single-stranded RNA, while DHX9, ADAR1, and NF90 bound a cognate double-stranded
RNA bait. PCBP2, IGF2BP1, and hnRNP L binding were blocked by preannealing the single-stranded RNA bait with miR-122,
indicating that they bind the RNA in competition with miR-122. However, IGF2BP1 binding was also inhibited by high concen-
trations of heparin, suggesting that it bound the bait nonspecifically. Among these proteins, small interfering RNA-mediated
depletion of hnRNP L and NF90 significantly impaired viral replication and reduced infectious virus yields without substantially
affecting HCV internal ribosome entry site-mediated translation. hnRNP L and NF90 were found to associate with HCV RNA in
infected cells and to coimmunoprecipitate with NS5A in an RNA-dependent manner. Both also associate with detergent-resis-
tant membranes where viral replication complexes reside. We conclude that hnRNP and NF90 are important host factors for
HCV replication, at least in cultured cells, and may be present in the replication complex.
IMPORTANCE
Although HCV replication has been intensively studied in many laboratories, many aspects of the viral life cycle remain obscure.
Here, we use a novel RNA pulldown strategy coupled with mass spectrometry to identify host cell proteins that interact function-
ally with regulatory RNA elements located at the extreme 5= end of the positive-strand RNA genome. We identify two, primarily
nuclear RNA-binding proteins, hnRNP L and NF90, with previously unrecognized proviral roles in HCV replication. The data
presented add to current understanding of the replication cycle of this pathogenic human virus.
Hepatitis C virus (HCV) is a leading cause of liver disease, in-cluding chronic hepatitis, cirrhosis, and hepatocellular carci-
noma. It is classified within the Flaviviridae family of viruses and
has a single-stranded, messenger-sense RNA genome 9.7 kb in
length. The replication of HCV viral RNA is uniquely dependent
on a host-factor microRNA (miRNA), miR-122, which is highly
abundant in liver (1, 2). There are two conserved miR-122 binding
sites (S1 and S2) located near the 5= end of the positive-sense HCV
RNA genome. Direct interactions between miR-122, and these
sites are essential for the HCV life cycle (3, 4). This is reflected
clinically in dose-dependent reductions of circulating HCV RNA
after intravenous administration of an antisense miR-122 “an-
tagomir” to HCV-infected chimpanzees and humans (5, 6).
Previous studies demonstrate that binding of miR-122 to the
5=-untranslated region (5=UTR) of the HCV genome stimulates
viral protein expression (7, 8) and also physically stabilizes the
RNA in infected cells (9, 10). Similar to conventional miRNA
action, miR-122 recruits Argonaute 2 protein (Ago2) to the viral
RNA (9, 11). The stability conferred by the miR-122/Ago2 com-
plex can be substituted functionally by addition of a 5= cap, sug-
gesting that it protects against 5=-exonuclease-mediated decay (9).
Indeed, studies of RNA decay pathways have revealed that HCV
RNA is primarily degraded from the 5= end by the exonuclease
Xrn1 in infected cells and that the binding of miR-122 to the HCV
5=UTR effectively blocks Xrn1-mediated degradation (10). How-
ever, depletion of Xrn1 in Huh-7.5 cells failed to rescue the repli-
cation of HCV RNA containing single-base substitutions in both
S1 and S2 that ablate miR-122 binding, suggesting that miR-122
has an additional, essential role in HCV replication beyond pro-
tecting the RNA genome from Xrn1-mediated degradation (10).
The 5=UTR of HCV folds into conserved stem-loops (SL1 to
SL4), with SL2 to SL4 participating in HCV internal ribosome
entry site (IRES)-directed translation (12, 13). The 5=UTR serves
as a platform to recruit proteins that are essential for viral protein
synthesis and RNA replication. Cellular RNA-binding proteins,
including eukaryotic initiation factor 3 (eIF3), the 40S ribosomal
subunit, polypyrimidine-tract-binding protein (PTB), poly(rC)-
binding protein 2 (PCBP2), and La autoantigen, have been shown
to bind to the 5=UTR of HCV RNA and to play important roles in
viral translation and/or replication (14–18). The miR-122 binding
sites (S1 and S2) are located upstream of SL2, encompassing the
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SL1 region and extending to the very 5= end of HCV RNA (Fig.
1A). This region has been shown to be essential for HCV RNA
replication (14, 19). Two proteins, Ago2 and PCBP2, are known to
associate with this region: Ago2 is recruited by miR-122, whereas
PCBP2 has been suggested to bind to SL1, a small stem-loop near
the 5= end (9, 14, 20). In the present study, we sought to identify
additional proteins associating with this region of the HCV ge-
nome, either dependently or independently of miR-122, and to
assess their function in HCV replication. We found that hnRNP L
and IGF2BP1 bind to single-stranded RNA (ssRNA) representing
the extreme 5= end of the HCV genome, whereas DHX9, ADAR1,
and NF90 associate with the cognate double-stranded RNA
(dsRNA). Among these proteins, hnRNP L and NF90 are shown to
be required for efficient HCV replication but not HCV IRES-di-
rected translation. Both proteins bind viral RNA in infected cells
and may be associated with viral replication complexes.
MATERIALS AND METHODS
Cells, reagents, and plasmids. Huh-7.5 cells (obtained from Charles Rice,
Rockefeller University) and FT3-7 cells were maintained as described pre-
viously (8, 21). U2OS cells with conditional expression of the HCV NS5A
protein were kindly provided by Darius Moradpour (Université de Laus-
anne) (22). WST-1 reagent (Millipore) was used to monitor cell prolifer-
ation according to the manufacturer’s suggested protocol. Plasmids
pH77S.3/GLuc2A and pHJ3-5 (both infectious HCV molecular clones)
have been described previously (8, 23). pHCVC-GLuc expresses an
HCV “minigenome” comprised of RNA sequence encoding the first 12
amino acids of the HCV core protein fused at its downstream end to the
Gaussia princeps luciferase (GLuc) sequence and flanked by the 5= and 3=
untranslated RNA sequences of H77S, a genotype 1a virus (24).
RNA transcription. Viral RNAs were transcribed in vitro as described
previously (9).
Biotinylated RNA pull-down. Oligoribonucleotide baits, H77S 1-47
and S1/S2p6 (Fig. 1A), representing the 5= 47 nucleotides of wild-type
genotype 1 HCV RNA and a related S1/S2p6 mutant (see below) and
conjugated to biotin at their 3= ends, were synthesized by Dharmacon
(Pittsburgh, PA). These RNA baits (10 pmol in each reaction) were incu-
bated alone or with 10 pmol of a similarly synthesized complementary
antisense oligonucleotide (to generate a dsRNA bait) or variable amounts
of single-strand synthetic miR-122 (9), heated at 75°C for 5 min, and then
cooled to room temperature. Annealed RNAs were bound to magnetic
streptavidin T1 beads (Invitrogen) according to the manufacturer’s in-
structions and then incubated with Huh-7.5 cell cytoplasmic lysate for 1 h
at 4°C. Anti-miR-122 or anti-random locked nucleic acid (LNA) oligonu-
cleotides (9) were added to the lysate where indicated. Proteins bound to
the beads were eluted with SDS-PAGE sample buffer, resolved by SDS-
PAGE and subjected to SYPRO Ruby staining or immunoblotting with
specific antibodies. Specific bands were cut from the gel and proteins in
each identified by mass spectrometry with the UNC Proteomics Core
Facility.
Transfections. siRNA pools targeting IGF2BP1, hnRNP L, ADAR1,
DHX9, NF90, and control small interfering RNA (siRNA) pools (Dhar-
macon) were transfected using siLentfect lipid reagent (Bio-Rad). In vitro-
transcribed HCV RNA (1.25 g) was transfected into 2.5  106 Huh-7.5
cells using the TransIT mRNA kit (Mirus Bio).
Real-time reverse transcription-PCR (RT-PCR). To quantify HCV
RNA, cDNA was produced by reverse transcription of RNA using oli-
go(dT) and an HCV-specific primer (5=-GGCCAGTATCAGCACTCTC
TGCAGTC-3=) targeting the 3=UTR of the genome and SuperScript III
reverse transcriptase (Invitrogen). Quantitative PCR analysis was carried
out using iTaq SYBR green Supermix with the CFX96 system (Bio-Rad).
HCV RNA abundance was determined by reference to a standard curve
using PCR primers targeting the 5=UTR (5=-CATGGCGTTAGTATGAG
TGTCGT-3= and 5=-CCCTATCAGGCAGTACCACAA-3=) and normal-
ized to the abundance of -actin mRNA (primers 5=-GTCACCGGAGTC
CATCACG-3= and 5=-GACCCAGATCATGTTTGAGACC-3=). The HCV
minigenome RNA was amplified by the primers 5=-CACGCCCAAGATG
AAGAAGT-3= and 5=-GAACCCAGGAATCTCAGGAATG-3=.
Immunoblots. Immunoblotting was carried out according to stan-
dard methods with the following antibodies: mouse monoclonal antibody
(MAb) to -actin (AC-74; Sigma-Aldrich); rat MAb to Ago2 (Sigma-
Aldrich); rabbit polyclonal antibodies to ADAR1, NF90, and DHX9
(Bethyl Laboratory); mouse MAb to hnRNP L (Millipore); rabbit poly-
clonal antibody to IGF2BP1 (Abcam); mouse MAb to PCBP2 (Abnova);
mouse MAb to hnRNP C and PTB (Abcam); MAb to HCV core protein
(Pierce); and rabbit polyclonal antibody to HCV NS5A protein (kindly
provided by Takaji Wakita). Protein bands were visualized with an Odys-
sey infrared imaging system (Li-Cor Biosciences).
Gaussia luciferase (GLuc) assay. Cell culture supernatant fluids were
collected at intervals after RNA transfection, and cells were refed with
fresh media. Secreted GLuc activity was measured in the supernatant flu-
ids using the Biolux Gaussia luciferase assay kit (New England BioLabs) as
previously described (23).
Infectious virus titration. Supernatant fluids (100 l) from HJ3-5
virus-infected cells were incubated with 5  104 uninfected Huh-7.5 cells
in a 48-well plate for 6 h. After replacement of media, cells were allowed to
grow for 72 h before fixation and immunolabeling with anti-core anti-
body (Pierce). Foci of infected cells were visualized and infectious virus
titer quantified in terms of focus-forming units as described previously
(24).
Preparation of cytoplasmic and nuclear lysates. Huh-7.5 cells were
harvested in lysis buffer A (150 mM KCl, 25 mM Tris-HCl [pH 7.5], 5 mM
EDTA,1% Triton X-100, 2 mM dithiothreitol, Complete protease inhib-
itor mixture [Roche, Mannheim, Germany]). Lysates were centrifuged for
5 min at 1,000  g at 4°C. The supernatants were collected as a cytoplas-
mic lysate. The nuclear pellet was washed with phosphate-buffered saline
and lysed in buffer B (500 mM KCl, 25 mM Tris-HCl [pH 7.5], 2 mM
EDTA, 1% NP-40, 0.1% SDS, Complete protease inhibitor mixture). Cy-
toplasmic and nuclear lysates were cleared by centrifugation at 17,000  g
for 10 min at 4°C.
Immunoprecipitation. Cytoplasmic lysates of HJ3-5 virus-infected
Huh-7.5 cells were incubated with anti-hnRNP L (Millipore), anti-NF90
(Bethyl Labs), anti-Dcp1a (Abnova), rabbit anti-NS5A (kindly provided
by T. Wakita), or isotype control IgG at 4°C for 2 h, followed by addition
of 30 l of protein G-Sepharose (GE Healthcare) for 1 h. RNase A was
added to the lysate where indicated. The Sepharose beads were washed
three times in lysis buffer. Proteins were eluted with SDS-PAGE sample
buffer and subjected to SDS-PAGE, followed by immunoblotting. Copre-
cipitated RNAs were extracted using the RNeasy minikit (Qiagen). HCV
RNA was detected by reverse transcription-PCR (RT-PCR) using the Su-
perScript One-Step RT-PCR (Invitrogen) and the specific primers 5=-CA
TGGCGTTAGTATGAGTGTCGT-3= and 5=-CCCTATCAGGCAGTAC
CACAA-3=.
Membrane flotation assay. The membrane flotation assay was carried
out according the method of Okamoto et al. (25) with some modifica-
tions. Eight million FT3-7 cells with or without HJ3-5 virus infection were
harvested, suspended in 1 ml of TNE buffer (25 mM Tris-HCl [pH 7.4]
containing 150 mM NaCl, 5 mM EDTA, and Complete protease inhibitor
cocktail), and then disrupted by 20 passages through a 25-gauge needle.
After low-speed centrifugation (1,000  g), postnuclear supernatants
were divided into two tubes and incubated for 30 min on ice with or
without 0.5% Triton X-100. The lysates were mixed with 1.2 ml of an
iodixanol (OptiPREP; Sigma-Aldrich, St. Louis, MO) solution with a final
concentration of 45%. This mixture was overlaid with a 35 to 10% iodix-
anol gradient and then centrifuged at 42,000 rpm and 4°C for 14 h in an
SW55 Ti rotor (Beckman Coulter, Fullerton, CA). Twelve fractions were
collected from the top of the gradient and precipitated with trichloro-
acetic acid, followed by acetone washing. Dried pellets were resolved in the
loading buffer, boiled, and subjected to SDS-PAGE, followed by immu-
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FIG 1 Identification of proteins binding to the 5= end of the HCV 5=UTR. (A) RNA baits used in the pulldown experiments. (Left) ssRNA oligonucleotide
representing the 5=most 47 bases in the HCV genome (H77S virus, black font). Two copies of miR-122 (red font) are shown bound to the probe as determined
by prior genetic studies (21). Positions involved in base-pairing are shown in boldface. (Right) S1/S2p6, a related bait with base substitutions (red font) at position
6 of the two miR-122 seed sequence binding sites, S1 and S2 (underlined). RNA probes were conjugated to biotin (diamond symbol) at their 3= ends. (B) RNA
pulldown. Synthetic biotinylated RNA bait (H77S 1-47) was incubated with Huh-7.5 cytoplasmic lysate by itself (ssRNA bait) or after being preannealed with a
complementary negative-strand RNA (dsRNA bait). Proteins pulled down were resolved by SDS-PAGE and stained by SYPRO Ruby. Unique protein bands in
each lane indicated by asterisks were identified by mass spectrometry. Mock, no RNA bait. (C) Protein samples from panel B were subjected to immunoblot
analysis with specific antibodies. 2% input lysate was loaded as reference. Ago2, IGF2BP1, hnRNP L and PCBP2 bind preferentially to ssRNA bait, while DHX9,
ADAR1, and NF90 bind to dsRNA bait. PTB was detected as a negative control. (D) RNA pulldown assay was done as in panel B using ssRNA bait in the presence
of the indicated amount of heparin. Ago2, PCBP2, IGF2BP1, and hnRNP L proteins were detected by immunoblotting. Heparin inhibited the binding of
IGF2BP1, but not the other proteins. (E) RNA pulldown assay was performed as in panel B using RNA bait containing single mutations in S1 and S2 site (S1/2p6,
see panel A). S1/S2p6 RNA demonstrated reduced binding of Ago2 and hnRNP L but not IGF2BP1 and PCBP2. (F) RNA pulldown assay was carried out as in
panel B except that anti-miR-122 or anti-random oligonucleotides were added to the lysate. Ago2, PCBP2, IGF2BP1, and hnRNP L proteins were detected by
immunoblotting. Anti-miR-122 blocked the binding of Ago2 but not the other proteins. (G) RNA pulldown assay was carried out as in panel B except that 10
pmol of ssRNA bait was preannealed with the indicated amount of single-strand miR-122 or miR-124. Ago2, PCBP2, IGF2BP1, and hnRNP L proteins were
detected by immunoblotting. The addition of miR-122 blocked the binding of PCBP2, IGF2BP1, and hnRNP L but not Ago2.
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noblotting. Protease treatment was carried out with 1 g of proteinase K
per 50-l fraction sample with or without 1% NP-40 and then incubated
at 37°C for 30 min.
Statistical tests. Statistical significance was calculated using Prism 5
for Mac OS X (GraphPad Software, Inc.) and specific statistical tests as
indicated.
RESULTS
To identify proteins that bind to the 5= terminus of positive-strand
HCV RNA, we used a biotin-tagged RNA pulldown strategy. A
synthetic oligonucleotide representing the 5= 47 nucleotides of
genotype 1 H77 virus was conjugated to biotin at its 3= end (Fig.
1A, left). This RNA bait (ssRNA bait) was incubated with Huh-7.5
cell cytoplasmic lysate. Since double-strand RNA is an important
intermediate in HCV RNA replication, we also sought to isolate
proteins that bind to a double-stranded version of this bait by
preannealing it with a complementary negative-strand RNA oli-
gonucleotide (dsRNA bait). The proteins associated with these
baits were pulled down with streptavidin beads, resolved by SDS-
PAGE, and visualized by SYPRO Ruby staining (Fig. 1B). Specific
bands that were pulled down by ssRNA or dsRNA bait were cut
from the gel and identified by mass spectrometry. We identified
three proteins that specifically associated with the ssRNA bait (Fig.
1B, lane 2, bands a, b, and c). These were identified by mass spec-
trometry as insulin-like growth factor 2 mRNA binding protein 1
(IGF2BP1), heterogeneous nuclear ribonucleoprotein L (hnRNP
L), and PCBP2, respectively. Three bands that specifically bound
the dsRNA bait (Fig. 1B, lane 3, bands A, B, and C) were found to
be DEAH box helicase 9 (DHX9, also known as ATP-dependent
RNA helicase 9), dsRNA-specific adenosine deaminase (ADAR1),
and “nuclear factor of activated T cells 90 kDa” (NF90; also known
as interleukin enhancer-binding factor 3 [ILF3]). To confirm the
mass spectrometry results, we used immunoblotting with specific
antibodies to these proteins. Consistently, we detected specific
binding of IGF2BP1, hnRNP L, and PCBP2 to the ssRNA bait and
binding of DHX9, ADAR1, and NF90 to the dsRNA bait (Fig. 1C).
As the 5=HCV RNA sequence contains both miR-122 binding
sites, we anticipated that endogenous miR-122 would bind with
Ago2 protein to the ssRNA bait (9). This was confirmed in immu-
noblots (Fig. 1C), although Ago2 was not visible by SYPRO Ruby
staining due to low abundance or inefficient binding of endoge-
nous miR-122 to the bait. In contrast, PTB, an RNA-binding pro-
tein required for HCV replication (16), did not appear to bind
either ssRNA or dsRNA bait in our assay and served as a negative
control (Fig. 1C). IGF2BP1, hnRNP L, and PCBP2 are all RNA-
binding proteins. PCBP2 has been shown to bind to the SLI region
of the HCV 5=UTR and to be required for HCV replication (14,
20). IGF2BP1 has also been found to bind to the 5= sequence of
HCV RNA and to modulate HCV IRES function (26, 27). hnRNP
L is a novel factor identified in our assay that has not been shown
previously to bind the 5= end of HCV RNA. DHX9, ADAR1, and
NF90 all contain double-strand RNA-binding motifs, which is
consistent with their binding to the dsRNA bait. DHX9 has RNA
helicase activity, ADAR1 is an RNA specific adenosine deaminase,
and NF90 was first discovered as a subunit of a nuclear transcrip-
tion factor complex (28). Their function in HCV replication has
not been well studied. To test the specificity of the interaction
between these RNA-binding proteins and the bait, we repeated the
ssRNA pulldown assay in the presence of a nonspecific competi-
tor, heparin (Fig. 1D). Increasing amounts of heparin reduced the
binding of IGF2BP1 but had little effect on the binding of Ago2,
PCBP2, or hnRNP L, confirming that Ago2 (miR-122), PCBP2
and hnRNP L interact with the HCV 5= terminal sequence in a
specific and likely sequence-dependent manner.
To determine whether the binding of IGF2BP1, hnRNP L, and
PCBP2 to the HCV 5= sequence is dependent on binding of miR-
122, such as Ago2 (9), we repeated the pulldown assay using a
mutant RNA bait that contains a single base substitution in both
the S1 and the S2 sites (Fig. 1A, right, S1/2p6) that significantly
reduces miR-122 binding. As expected (9), the mutation substan-
tially reduced Ago2 binding (Fig. 1E). Interestingly, it also dimin-
ished binding of hnRNP L but not PCBP2 or IGF2BP1 (Fig. 1E),
which suggests that hnRNP L binding might be dependent on
miR-122. To assess this further, we carried out a pulldown assay in
the presence of an antisense anti-miR-122 locked nucleic acid
(LNA) oligonucleotide. However, while the antagomir dramati-
cally reduced Ago2 binding to the ssRNA bait, there was no effect
on the binding of any of the other proteins, indicating that they
bind to HCV RNA independently of miR-122 (Fig. 1F). Therefore,
the reduced binding of hnRNP L to the p6 mutant RNA is unlikely
to be due to reduced miR-122 binding and is more likely caused by
direct disruption of the hnRNP L binding site. If this is the case, it
indicates that hnRNP L binds to the same or overlapping site as the
miR-122 seed sequence. Indeed, when we preannealed miR-122 to
the ssRNA bait, the binding of hnRNP L was dramatically de-
creased in a miR-122 dose-dependent manner (Fig. 1G). Surpris-
ingly, the binding of IGF2BP1 and PCBP2 was also blocked by
miR-122. These data indicate that IGF2BP1, hnRNP L, and
PCBP2 bind the HCV 5= sequence in competition, not in cooper-
ation with miR-122. This is not surprising given the extensive
interactions of miR-122 with this segment of the viral genome
(Fig. 1A, left).
We next sought to determine whether proteins that bind the 5=
end of HCV RNA have a function in HCV replication. Since Ago2
and PCBP2 have already been demonstrated to be required for
HCV replication, we focused on the other proteins detected in our
pulldown assay, including IGF2BP1, hnRNP L, ADAR1, DHX9,
and NF90. We knocked down the expression of these proteins by
transfecting specific siRNAs into Huh-7.5 cells (Fig. 2A) and then
transfected a modified HCV genomic RNA that expresses Gaussia
princeps luciferase (GLuc) as a reporter. Secreted GLuc activity
was monitored over 72 h as an indicator of HCV replication (9).
siRNA-mediated depletion of hnRNP L and NF90 substantially
reduced HCV replication. Depletion of IGF2BP1 and DHX9
caused much smaller but nonetheless reproducible and statisti-
cally significant reductions in replication, while ADAR depletion
was without effect (Fig. 2B). These results suggested that, among
these RNA-binding proteins, hnRNP L and NF90 may be partic-
ularly important for efficient HCV replication. However, deple-
tion of either protein also caused significant defects in cell prolif-
eration as measured by WST-1 assay, in both cases reducing cell
growth by ca. 25% (Fig. 2C).
Further studies focused on hnRNP L and NF90. To minimize
the impact of their depletion on cell growth, we repeated the RNA
interference experiments in cells cultured in media containing 2%
serum (Fig. 3). HCV replication was significantly reduced by de-
pletion of either protein, as measured by GLuc activity (Fig. 3A).
Total HCV RNA abundance was also reduced by ca. 60%, after
hnRNP L depletion and 40% after NF90 depletion (Fig. 3B). Im-
portantly, hnRNP L and NF90 depletion resulted in little change
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in cell proliferation (Fig. 3C). We confirmed these results by in-
fecting Huh-7.5 cells with HJ3-5 virus, an HCV genotype 1a/2a
chimera that efficiently replicates and produces infectious parti-
cles in cell culture. Knockdown of hnRNP L dramatically dimin-
ished HJ3-5 replication, as measured by expression of HCV core
and NS5A proteins; knockdown of NF90 also modestly reduced
the abundance of core and NS5A proteins (Fig. 3D). Consistently,
hnRNP L and NF90 knockdown resulted in 3- and 1.5-fold reduc-
tions in infectious virus yield after 72 h compared to cells trans-
fected with a nontargeting control siRNA (Fig. 3E). The above-
described experiments used siRNA pools targeting hnRNP L and
NF90. To assess the possibility that inhibition of replication re-
sulted from off-target effects of these siRNAs, we compared the
knockdown efficiency of individual siRNAs with their impact on
viral replication. We observed substantial variation in the capacity
of individual siRNAs to deplete hnRNP L or NF90 (Fig. 3F), but
with both proteins the degree of depletion strongly correlated with
the magnitude of the reduction in HCV replication, as measured
by GLuc assay (Fig. 3G). Thus, the reduction of HCV replication
was likely caused by specific depletion of hnRNP L and NF90 and
not spurious off-target effects of the siRNA. Collectively, these
data strongly suggest a role for hnRNP L and NF90 in efficient
HCV genome amplification.
To examine whether hnRNP L and NF90 are required for HCV
IRES-mediated translation, we transfected cells with an HCV
minigenome RNA comprised of the HCV 5=UTR and 3=UTR
flanking the GLuc sequence as reporter (Fig. 4A). This RNA was
transfected into Huh-7.5 cells depleted of hnRNP L and NF90, and
secreted GLuc activity was measured over the ensuring 24 h. De-
pletion of hnRNP L and NF90 resulted in little difference in GLuc
activity (Fig. 4B) or GLuc mRNA abundance at 24 h (Fig. 4C).
These data suggest that hnRNP L and NF90 are not essential for
HCV IRES-mediated translation and that they do not significantly
influence the stability of RNAs containing the HCV 5=UTR. Since
hnRNP L binds to the 5= end of HCV RNA in competition with
miR-122 (Fig. 1F), while NF90 binds nearby, we also tested
whether hnRNP L and NF90 depletion would affect the capacity of
miR-122 to promote HCV replication. We transfected H77S.3/
GLuc2A RNA into control, hnRNP L- or NF90-depleted cells,
together with miR-122 or miR-124. Consistent with previous re-
ports (9, 10), miR-122 supplementation resulted in an 2-fold
increase in GLuc activity compared to a control miRNA, miR-124
(Fig. 4D). The fold increase in GLuc activity caused by miR-122
supplementation (2.06) was unchanged in hnRNP L- and NF90-
depleted cells (1.95 to 2.06, Fig. 4D), indicating that significant
reductions in hnRNP L and NF90 abundance do not influence
miR-122 enhancement of HCV replication.
hnRNP L and NF90 have been reported to be nuclear proteins
(29–31). We confirmed this by laser-scanning confocal fluores-
cence microscopy (data not shown). However, since the HCV life
cycle is restricted to the cytoplasm, we further analyzed the distri-
bution of hnRNP L and NF90 in Huh-7.5 cells by cytoplasmic-
nuclear fractionation. As shown in Fig. 5A, hnRNP L was largely
localized to the nuclear fraction, and yet a small proportion of it
was present in cytoplasm. Approximately half of the NF90 abun-
dance localized to the cytoplasm, while NF110, an isoform of
NF90, was predominantly detected in the nuclear fraction. NF90
and NF110 share antigenic specificity, and this likely explains the
discrepant microscopy findings. HCV infection did not alter the
intracellular distribution of hnRNP L or NF90 (Fig. 5A, right).
To determine whether hnRNP L and NF90 bind to HCV RNA
in infected cells, as they do in vitro (Fig. 1), we immunoprecipi-
tated hnRNP L and NF90 from HJ3-5 virus-infected Huh-7.5 cells
and examined the precipitate for the presence of viral RNA. hn-
RNP L and NF90 were efficiently pulled down by specific antibod-
ies compared to an isotype control IgG (Fig. 5B). RNA coprecipi-
tating with hnRNP L and NF90 was purified and HCV RNA
amplified and detected by RT-PCR. As shown in Fig. 5B, HCV
RNA coprecipitated with both hnRNP L and NF90, indicating that
hnRNP L and NF90 associate with HCV RNA within infected
cells. In contrast, antibody to Dcp1a, an mRNA-decapping pro-
tein that does not colocalize with HCV RNA in cells (10), did not
pull down HCV RNA. hnRNP L and NF90 were also found to
coprecipitate with NS5A in HCV-infected cells by immunoblot
assay (Fig. 5C). This association was RNA dependent since RNase
treatment completely abolished the interaction (Fig. 5C). To de-
termine whether the RNA mediating the interaction between
NS5A and hnRNP L or NF90 is HCV specific, we repeated this
FIG 2 Depletion of hnRNP L or NF90 impairs HCV replication. Huh-7.5 cells were transfected with siRNAs targeting the indicated proteins or scrambled si-Ctrl
and then 48 h later retransfected with H77S.3/GLuc2A RNA. (A) Immunoblots of IGF2BP1, hnRNP L, ADAR1, DHX9, and NF90 72 h after siRNA transfection.
-Actin was included as a loading control. The percent depletion of each protein is shown. (B) Relative GLuc activity in supernatant fluids from Huh-7.5 cells
transfected with HCV RNA and the indicated siRNAs. The results shown represent the means of three replicate experiments  the standard deviations. Values
at 6 h were arbitrarily set to 100. **, P  0.01 (compared to si-Ctrl by two-way analysis of variance [ANOVA]). (C) WST-1 assay measurement of proliferation
of cells transfected with indicated siRNAs at 72 h after HCV RNA transfection. Values for control siRNA were arbitrarily set to 100. **, P  0.01(compared to
si-Ctrl by two-way ANOVA with Bonferroni’s multiple-comparison test.)
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assay using U2OS cells that conditionally express only the NS5A
protein (Fig. 5D). Little interaction was evident between NS5A
and hnRNP L or NF90 under these conditions (Fig. 5E), suggest-
ing that the coprecipitation of hnRNP L and NF90 with NS5A in
infected cells may be largely mediated by HCV RNA. We found no
evidence that either protein directly interacts with NS5A.
Previous studies indicate that HCV RNA replication com-
plexes are localized to detergent-resistant intracellular mem-
FIG 3 hnRNP L and NF90 are required for efficient HCV replication. (A) Huh-7.5 cells were maintained in growth media containing 2% serum, and transfected with
siRNAs for hnRNP L, NF90, or scrambled si-Ctrl and then 48 h later retransfected with H77S.3/GLuc2A RNA. Supernatant fluids were removed at intervals and assayed
for GLuc activity. Values at 6 h were arbitrarily set to 100. The results shown represent the means of three replicate experiments  the standard errors of the mean. *, P 
0.05; **, P  0.01 (compared to si-Ctrl by two-way ANOVA). (B) HCV RNA was quantified relative to -actin mRNA by real-time RT-PCR 72 h after HCV RNA
transfection. *, P  0.05; **, P  0.01 (compared to si-Ctrl by one-way ANOVA with Bonferroni’s correction for multiple comparisons). (C) WST-1 assay for
measurement of proliferation of cells at 72 h after HCV RNA transfection. Values for control siRNA were arbitrarily set to 100. Values do not differ significantly from
si-CTRL (one-way ANOVA with Bonferroni’s post test). (D) Immunoblots of HCV core and NS5A proteins at 72 h postinfection, with -actin as a loading control.
Huh-7.5 cells were maintained in growth medium containing 2% serum and transfected with siRNAs for hnRNP L, NF90, or scrambled si-Ctrl and then 48 h later
infected with HJ3-5 virus. Italicized labels show quantification of core and NS5A proteins relative to-actin, with values for si-Ctrl arbitrarily set to 100. (E) The infectious
virus titers of supernatant fluids from panel D were determined by a fluorescent focus formation assay. The results shown represent the means of three replicate
experiments  the standard deviations. *, P  0.05; **, P  0.01 (compared to si-Ctrl by one-way ANOVA with Bonferroni’s post test). (F) Individual siRNAs targeting
hnRNP L or NF90 (four each) were transfected into cells, and hnRNP L and NF90 protein abundance was determined by immunoblotting 96 h later. -Actin was
included as a loading control. hnRNP L and NF90 levels were normalized to -actin, and the percent depletion compared to si-Ctrl was calculated for each siRNA. (G)
H77S.3/GLuc2A RNA was transfected into the hnRNP L- and NF90-depleted cells shown in panel F, and GLuc activity secreted from the cells between 48 and 72 h was
assessed. The results shown represent mean GLuc  the standard deviations in three replicate cultures, plotted against the percent depletion of target protein. Dashed
lines represent the outer limits of the 95% confidence-interval band for a best-fit plot. The P values indicate the likelihood that the slope of this line diverges from “0”.
Inhibition of HCV replication was highly correlated with the degree of depletion of hnRNP L and NF90.
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branes (DRMs) (32). Thus, to examine the possibility that hnRNP
L and NF90 might be associated with replication complexes, we
investigated their distribution within membrane fractions recov-
ered from a flotation gradient. Cytoplasmic membranes from un-
infected or HJ3-5 virus-infected Huh-7.5 cells were treated with
Triton X-100, overlaid with a density gradient, and subjected to
centrifugation (see Methods). Partitioning of DRMs and deter-
gent soluble membranes (DSM) into separate fractions was con-
firmed by distinct distributions of caveolin-2 and calrecticulin
among these fractions (Fig. 6A). HCV replication complexes were
largely associated with the DRM, as shown by the distribution of
NS5A. Although hnRNP L and NF90 were readily detected in
DRM fractions from uninfected cells (3.0 to 6.85% and 2.2 to
3.2% of the total of hnRNP L and NF90, respectively, in the gra-
dient were present in fractions 1 to 4), HCV infection increased
the proportion of the proteins associating with the DRM (10.0 to
21.9% hnRNP L and 12.7 to 27.6% NF90 in replicate experiments)
(Fig. 6A and B). In contrast, IGF2BP1, which binds nonspecifically
to our RNA bait (Fig. 1D) and the depletion of which had rela-
tively little effect on HCV replication (Fig. 2B), was barely detect-
able in DRM fractions, and its distribution was not altered by
HCV infection (Fig. 6A). These data indicate that HCV infection
results in an increased association of hnRNP L and NF90 with
DRMs, providing additional evidence that these proteins are likely
to be associated with the replication complex.
To further confirm this association, we treated the DRM frac-
tions with proteinase K. Proteins present within membranous ves-
icles within the DRM fraction should be resistant to proteases in
the absence of strong detergents. hnRNP L and NF90 in DRM
fractions from uninfected cells were completely digested by pro-
teinase K (Fig. 6C), indicating that they are not protected by mem-
branes. In contrast, a significant fraction of hnRNP L and NF90 in
DRM fractions from HCV-infected cells was resistant to protease
treatment (Fig. 6C). Pretreatment of these fractions with 1% NP-
40, which should disrupt all membrane structures, rendered these
proteins sensitive to proteinase K. Taken together with the in-
creased distribution of hnRNP L and NF90 into the DRM frac-
tions (Fig. 6A and B), these data suggest that hnRNP L and NF90
are recruited into replication complexes to facilitate replication.
DISCUSSION
The 5=-terminal sequence of the HCV genome contains two miR-
122 binding sites and is known to have an important regulatory
role in viral RNA replication (3, 4, 19). The predicted secondary
structure of the 47-nucleotide terminal sequence contains a con-
served stem-loop (SLI), followed by an unstructured region
within which the miR-122 seed sequence-binding sites are located
(Fig. 1A, left). We hypothesized that these conserved regions may
interact with host proteins that regulate viral RNA translation
and/or replication. To assess this hypothesis, we used a biotin-
RNA pulldown strategy to identify proteins that bind to this 5=-
terminal sequence. In addition to Ago2 and PCBP2, which have
FIG 4 hnRNP L and NF90 depletion do not affect HCV IRES translation or miR-122 enhancement of HCV replication. (A) Diagram of the HCV minigenome
RNA comprising the HCV 5=UTR followed by N-terminal core protein sequence fused to GLuc and the HCV 3= UTR. (B) Huh-7.5 cells were transfected with
siRNAs for hnRNP L, NF90 or scrambled si-Ctrl, and then 48 h later retransfected with HCV minigenome RNA. GLuc activity in supernatant fluids was measured
at indicated times. The results shown represent the means of three replicate experiments  the standard deviations. Values at 3 h were arbitrarily set to 100. (C)
GLuc RNA levels were determined by real-time RT-PCR 24 h after HCV minigenome RNA transfection relative to -actin mRNA. The differences in GLuc
activity between hnRNP L- and NF90-depleted cells and cells transfected with si-Ctrl at 24 h (see panel B) were not significant when normalized to mRNA
abundance (P 	 0.05 as determined by two-sided t test). (D) Huh-7.5 cells were transfected with siRNAs for hnRNP L, NF90, or scrambled si-Ctrl and then 48
h later retransfected with H77s-GLuc RNA, together with 100 nM duplex miR-122 or miR-124. The GLuc activities were measured 72 h later. The results shown
represent the means of three replicate experiments  the standard deviations. **, P  0.01 (compared to miR-124 by two-sided t test).
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been shown previously to bind this region of the genome (9, 14,
20), we documented the binding of several novel proteins, includ-
ing hnRNP L, DHX9, ADAR1, and NF90 (Fig. 1B and C). hnRNP
L binds ssRNA, whereas DHX9, ADAR1, and NF90 bind the dou-
ble-strand complement of this RNA segment. Among these pro-
teins, siRNA-mediated knockdowns of either hnRNP L or NF90
reduced HCV RNA and protein levels within infected cells (Fig. 3),
suggesting that both are required for efficient HCV replication.
hnRNP L and NF90 function in the HCV life cycle independently
of miR-122, because depletion of either did not affect the capacity
of miR-122 to stimulate HCV replication (Fig. 4D). hnRNP L and
NF90 depletion had no impact on GLuc activity expressed by an
HCV minigenome (Fig. 4B), suggesting they are not required for
HCV IRES-mediated translation.
Previous studies have demonstrated that HCV RNA replica-
tion complexes consist of viral and host proteins assembled on
DRMs (32). The localization of hnRNP L and NF90 to the DRM
fractions of HCV-infected cells (Fig. 6A and B) thus suggests that
they may be associated with the RNA replication complex. The
fact that both proteins are protected by membranes from protease
digestion in these DRM fractions provides further support for this
(Fig. 6C). Immunoprecipitation of hnRNP L and NF90 in HCV-
infected cells confirmed their association with HCV RNA (Fig.
5B). It is particularly interesting that hnRNP L and NF90 coim-
munoprecipitated with NS5A (Fig. 5C), an essential component
of the replication complex. The interaction was dependent on
RNA, suggesting that while hnRNP L and NF90 do not physically
interact with NS5A, they may form an RNA-protein complex to-
gether, possibly in association with HCV RNA in the replication
complex.
hnRNPs are proteins that interact with heterogeneous nuclear
RNAs (hnRNAs) (33). Several functions have been suggested for
hnRNPs, including pre-mRNA processing, mRNA translocation
from the nucleus to the cytoplasm, and translation (33). This
group of RNA-binding proteins has been shown to participate in
both viral IRES mediated-translation and viral replication. For
example, PTB (hnRNP I) has been shown to enhance IRES-de-
pendent translation of encephalomyocarditis virus and foot-and-
mouth disease virus, both picornaviruses, as well as HCV (16, 34,
35). PCBP2 (hnRNP E2) is required for efficient translation and
replication of both poliovirus and HCV RNA (14, 36). hnRNP L
has been reported to be localized mainly in the nucleus (29). How-
ever, we detected hnRNP L in the cytoplasm both in the presence
and in the absence of HCV infection (Fig. 5), suggesting that it
may shuttle between the nucleus and cytoplasm. hnRNP L was
previously reported to be required for HCV IRES-dependent
translation because an RNA aptamer specific for hnRNP L
blocked reporter protein translation directed by the HCV IRES
FIG 5 Cellular localization and association of hnRNP L and NF90 with HCV RNA and NS5A. (A) Distribution of hnRNP L and NF90 in cytoplasmic and nuclear
fractions. Total lysate and cytoplasmic and nuclear fractions of Huh-7.5 cells with or without HCV infection were prepared, and the distribution of the indicated
proteins was assessed using immunoblotting. hnRNP L was largely localized to the nuclear fraction, with a small amount in the cytoplasm. NF90 protein was
equally distributed between cytoplasmic and nuclear fractions, while NF110, an isoform of NF90, predominantly localized to the nucleus. GAPDH (glyceralde-
hyde-3-phosphate dehydrogenase) was used as cytoplasmic marker and hnRNP C as a nuclear marker. HCV NS5A protein was detected only in the cytoplasmic
fraction from infected cells. (B) hnRNP L and NF90 associate with HCV RNA in infected cells. hnRNP L or NF90 proteins were immunoprecipitated by specific
antibodies from a cytoplasmic lysate of Huh-7.5 cells infected with HJ3-5 virus. Precipitation of hnRNP L and NF90 proteins was confirmed by immunoblotting.
RNAs were extracted from the precipitates, and HCV RNA was detected by RT-PCR. Isotype control IgG was used as negative control. 5% input lysate was loaded
as a reference. (C) RNA-dependent association of NS5A with hnRNP L and NF90. NS5A protein was immunoprecipitated by specific antibody or control IgG
from HJ3-5 virus-infected Huh-7.5 cytoplasmic lysate with or without RNase treatment. NS5A, hnRNP L, and NF90 proteins in the precipitates were detected
by immunoblotting. 5% input lysate was loaded as reference. hnRNP L and NF90 coimmunoprecipitate with NS5A only in non-RNase-treated samples. (D)
U2OS cells with tet-regulated expression of NS5A protein were treated with or without 2 g of tetracycline/ml for 48 h, and the expression of NS5A was detected
by immunoblotting with GAPDH as a loading control. (F) NS5A immunoprecipitation was carried out as in panel C for U2OS cells expressing NS5A protein.
Little coprecipitation of hnRNP L and NF90 with NS5A was observed.
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(37). However, in our study hnRNP L had little effect on the trans-
lation of a minigenome reporter containing both HCV UTRs,
indicating that it is not essential for HCV IRES-dependent trans-
lation initiation (Fig. 4). It is possible the aptamer used in the
previous report caused a nonspecific inhibition of IRES activity.
It is intriguing that the hnRNP L protein binding site appears
to overlap with miR-122 binding sites in HCV 5=UTR, since the p6
mutation in the S1 and S2 sites reduced hnRNP L binding to the
RNA bait in the pulldown experiments (Fig. 1E). However, the
binding of hnRNP L to the HCV 5= terminus is independent of
miR-122, since the anti-miR-122 antagomir did not block binding
of hnRNP L (Fig. 1F). In contrast, preincubation of the RNA bait
with miR-122 diminished hnRNP L binding, indicating that hn-
RNP L and miR-122 bind competitively to overlapping sites. It is
puzzling why two proviral factors, miR-122 and hnRNP L, would
compete with each other. One plausible explanation is that hn-
RNP L and miR-122 are involved in different stages of the HCV
life cycle and that a change of binding factors at the 5= RNA ter-
minus is accompanied by a transition between these different
stages. Further work will be required to investigate this hypothesis.
NF90 belongs to a family of proteins that contain a double-
strand RNA binding motif and exert a variety of functions involv-
ing RNA recognition, RNA processing, and RNA stability (38).
NF90 has previously been reported to form a complex with DHX9
FIG 6 Membrane flotation assay. (A) Analysis of the distribution of hnRNP L and NF90 in fractions recovered from a membrane flotation assay. Cytoplasmic
membranes extracted from FT3-7 cells with or without HCV infection were treated or not treated with Triton X-100, overlaid with a density gradient, and
subjected to centrifugation. Fractions were subsequently recovered from the top of the gradient, and proteins in each were precipitated, resolved by SDS-PAGE,
and analyzed by immunoblotting. Calrecticulin and caveolin-2 were detected as markers for detergent-soluble membrane (DSM) and detergent-resistant
membrane (DRM), respectively. A substantial proportion of NS5A was located in DRM fractions, consistent with its presence in the HCV replication complex.
hnRNP L and NF90 were readily detected in DRM, while little IGF2BP1 protein was found present in DRM. The image shown is representative of replicate
experiments. (B) Quantification of the distribution of hnRNP L and NF90 proteins in fractions from the flotation gradients shown in panel A. Protein bands in
immunoblots of each fraction were quantified with an Odyssey infrared imaging system. (C) hnRNP L and NF90 distributed to the DRM are protected from
protease digestion in gradients loaded with material from HCV-infected cells. Fractions 2 and 3 (no Triton X-100) from panel A were treated with proteinase K
with or without prior treatment with 1% NP-40. hnRNP L and NF90 proteins were detected by immunoblotting. hnRNP L and NF90 were uniformly sensitive
to protease K in uninfected cells, whereas hnRNP L and NF90 associating with the DRM were resistant to proteinase K in HCV-infected cells. All proteins in
fractions 8 and 9 from either uninfected or infected cells were sensitive to protease treatment (data not shown).
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(39). Although DHX9 and NF90 both bound to the dsRNA bait
(Fig. 1), depletion of NF90 had a much greater impact on HCV
replication (Fig. 2B). NF90 has been shown to positively regulate
replication of several positive-strand RNA virus, including dengue
virus and bovine viral diarrhea virus, a pestivirus closely related to
HCV (40, 41). This suggests its host factor function may be con-
served among the Flaviviridae. It binds to the 5=UTRs and/or
3=UTRs of these viruses and promotes their replication. It has also
been reported to associate with both the 5=UTRs and 3=UTRs of
HCV in a cross-linking assay and to promote interactions between
the 5= and 3= ends of the genome (42). Although we found that
NF90 bound to the dsRNA bait (Fig. 1) and was required for
efficient HCV replication (Fig. 3), we do not know whether NF90
mediates HCV replication through its direct association with
dsRNA (as we have demonstrated) or by binding to structured
elements within the HCV 5=UTRs and 3=UTRs. Nevertheless, the
increased distribution of NF90 into DRM following HCV infec-
tion (Fig. 6) suggests the association of NF90 with viral replicase
complexes.
How hnRNP L and NF90 function in HCV replication remains
to be determined. The binding of hnRNP L or NF90 could facili-
tate replication complex assembly by recruiting other viral and
host factors onto HCV RNA or possibly induce conformational
changes in the RNA that promote viral RNA synthesis. Further
studies are needed to dissect the individual steps in the viral life
cycle impacted by hnRNP L and NF90 and to identify other host
and viral proteins involved. Further elucidation of the molecular
basis of the function of hnRNP L and NF90 on HCV replication
could yield important insight into unrecognized actions of RNA-
binding proteins in the viral life cycle and possibly provide clues
for development of broadly acting antiviral therapies.
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